Riverside Acceleration Capital Fund III has provided secured growth financing to Abi Global Health, the Dublin AI-first virtual care platform, with RAC III Abi Global Health, LLC named as security agent on an Irish all-assets debenture.
Riverside Acceleration Capital’s public blog later framed the deal as an “investment” without specifying a loan or disclosing the size.
Irish Companies Registration Office filings show a Form C1 charge created on 7 July 2026 for ABI Global Health Limited (CRO 588702). The persons entitled to the charge are RAC III Abi Global Health, LLC, of 630 Fifth Avenue, Suite 400, New York.
A charge was received on 9 July 2026 and the C1 does not state a secured amount.
Further particulars describe a first fixed and floating charge over the company’s assets — a standard all-assets debenture. The Riverside Company portfolio lists Abi under Riverside Acceleration Capital with an Invested date of July 2026 and Strategy Flexible Capital, consistent with the July security package.
Abi, founded in 2016, connects patients with licensed healthcare professionals on demand through an AI-powered navigation and clinician-matching system.
The structure parallels Riverside Acceleration Capital’s Soter financing, where UK Companies House charges named Riverside Acceleration Capital Fund III as chargee behind similarly equity-flavoured public language.